City Therapeutics, Inc (CTY) vs Immatics N.V. (IMTX)

City Therapeutics, Inc CTY 18.56 +8.73%
Immatics N.V. IMTX 6.34 +2.59%

City Therapeutics, Inc and Immatics N.V. are both Biotechnology companies. City Therapeutics, Inc and Immatics N.V. are of similar size ($924.8M and $882.9M).

Metric	CTY	IMTX	Biotechnology median
P/E	—	n/m	10.60
P/S	—	17.61	9.40
P/B	—	1.87	2.13
Price to free cash flow	—	n/m	25.18
EV/EBITDA	—	n/m	0.66
EV/Sales	—	12.12	9.02
Earnings yield	—	(29.34%)	(32.88%)
Free cash flow yield	—	(27.74%)	(23.13%)

Metric	CTY	IMTX	Biotechnology median
Gross margin	—	100.00%	68.51%
Operating margin	—	(536.26%)	0.00%
Net margin	—	(489.35%)	0.00%
Free cash flow margin	—	(488.01%)	0.00%
Return on equity	—	(48.53%)	(51.96%)
Return on assets	—	(39.83%)	(46.06%)
Return on invested capital	—	(84.83%)	0.00%

Metric	CTY	IMTX	Biotechnology median
Revenue growth (TTM)	—	(64.99%)	6.76%
EPS growth (last fiscal year)	—	(1,313.33%)	29.88%
Revenue growth, 5-year CAGR	—	11.81%	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	CTY	IMTX	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	7.54	4.97
Net debt to EBITDA	—	2.04	1.01

Metric	CTY	IMTX	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	CTY	IMTX	Biotechnology median
Market cap	882.88m	924.75m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack